Michael Pavlak
Keine laufenden Positionen mehr
Profil
Michael Pavlak is Vice President of Business Development for PLIVA, Inc. Prior to joining PLIVA in March 2005, he was Senior Vice President of DSM Corp.
and President of DSM Pharma Chemicals USA. Before DSM, Mr. Pavlak was Vice President and General Manager of the USA Generics Business for Siegfried, Inc. He has 30 years of experience in the chemical and pharmaceutical industries.
Mr. Pavlak received a BS degree in Mechanical Engineering (BSME) from Newark College of Engineering (now New Jersey Institute of Technology) and an MBA in Finance from Temple University.
Ehemalige bekannte Positionen von Michael Pavlak
| Unternehmen | Position | Ende |
|---|---|---|
| DSM Corp. | Corporate Officer/Principal | - |
PLIVA, Inc.
 PLIVA, Inc. Drugstore ChainsRetail Trade PLIVA, Inc. develops, produces, and sells drugs and pharmaceutical products. Its products include Ethosuximide, Fluoxetine, and Cyclosporine. The company was founded in 1921 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Ausbildung von Michael Pavlak
| Temple University (Pennsylvania) | Masters Business Admin |
| New Jersey Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
PLIVA, Inc.
PLIVA, Inc. Drugstore ChainsRetail Trade PLIVA, Inc. develops, produces, and sells drugs and pharmaceutical products. Its products include Ethosuximide, Fluoxetine, and Cyclosporine. The company was founded in 1921 and is headquartered in East Hanover, NJ. | Retail Trade |
| DSM Corp. |
